accountClinical trials of Celgene's (CELG) Revlimid, Bayer (BAYG.DE) and Onyx Pharmaceutical's (ONXX) Nexavar, Novartis' (NVS) Zometa, and Genentech's (DNA) Avastin will all be closely watched at the meeting. On the experimental side, data on Avant...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Cancer Research Group Releases Data
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account